Sunday, 1 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Merger & Restructuring

Windlas Biotech Merger & Restructuring

Windlas Biotech Limited has scheduled a Board meeting on April 17, 2026, to consider a proposal for the buyback of its fully paid-up equity shares. Trading window for designated persons remains closed from April 1, 2026, until 48 hours after the declaration of financial results for the year ended March 31, 2026.

Source

BSE filing, NSE: WINDLAS. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Windlas Biotech Ltd: key numbers

Share price
₹876.10
Market cap
₹1,839 Cr
Revenue (annual)
₹904.1 Cr
Net profit (annual)
₹66.44 Cr
P/E (TTM)
27.7×Sector 45.9×
Promoter holding
63.31%+0.00% QoQ
FII holding
2.09%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Windlas Biotech Ltd

All →

Other merger & restructuring announcements

All →